National & International Grants
Nationally Funded Projects
- Harnessing vulnerabilities at SAGA in MYC-driven malignancies
CCRI responsible Principal Investigator: Davide Seruggia
Grant from the Austrian Science Fund (FWF), Stand-Alone Project, ID – P 36069-B
Duration: 01/01/2023 to 31/12/2025 - Regulating CAR T cells with a safe and naturally occurring drug
CCRI responsible researcher: Elise Sylvander (supervisor: Manfred Lehner)
Grant from the Austria Academy of Sciences (ÖAW), DOC fellowship, ID – 26323
Duration: 01/07/2022 to 01/07/2024
https://ccri.at/doc-fellowship-recipient-elise-sylvander-develops-safety-system-for-car-t-cells/ - MetLung, an innovative 3D lung metastasis model
CCRI responsible Principal Investigator: Heinrich Kovar
Grant from the Austrian Science Fund (FWF) & Federal Ministry of Education, Science and Research (BMBWF), ID – P 35353
Duration: 02/05/2022 to 01/05/2025
https://www.fwf.ac.at/en - Mapping metastatic cancer by multi-modal imagine (MAPMET)
CCRI responsible Principal Investigator: Sabine Taschner-Mandl
Grant from the Austrian Science Fund (FWF), Stand-Alone Project, ID – P 35841
Duration: 01/05/2022 to 30/04/2026
https://www.fwf.ac.at/en - Non-canonical STAT1 signaling in natural killer cells
CCRI responsible Principal Investigator: Eva König
Grant from the Austrian Science Fund (FWF), Stand-Alone project, ID – P 34832
Duration: 01/01/2022 to 31/12/2025
https://www.fwf.ac.at/en - Cracking the ribosome code of drug resistance in sarcomas
CCRI responsible Principal Investigator: Eleni Tomazou
Grant from the Austrian Science Fund (FWF), Thousand Ideas Project, ID – TAI 592
Duration: 01/01/2022 to 31/10/2023
https://www.fwf.ac.at/en - Decoding the epigenome and its regulation in neuroblastoma
CCRI responsible researcher: Irfete Fetahu (supervisor: Sabine Taschner-Mandl)
Grant from the Austrian Science Fund (FWF), Stand-Alone Project, ID – P 35072
Duration: 01/12/2021 to 30/11/2024
https://www.fwf.ac.at/en/ - Interplay of fusion genes and cellular context in sarcoma
CCRI responsible Principal Investigator: Eleni Tomazou
Grant from the Austrian Science Fund (FWF), Stand Alone Project, ID – P 34958
Duration: 01/10/2021 to 30/09/2025
https://www.fwf.ac.at/en/ - Comprehensive cell contact tracing (C3T)
CCRI responsible Principal Investigator: Florian Halbritter
Additional CCRI Principal Investigators: Martin Distel
Grant from the Austrian Science Fund (FWF), TAI-1000 Ideas Program, ID – TAI 454
Duration: 01/09/2021 to 31/12/2022
https://www.fwf.ac.at/en/news-and-media-relations/news/detail/nid/20210707-0 - Validation of a liquid biopsy based molecular diagnostic toolkit for pediatric sarcomas
CCRI responsible Principal Investigator: Eleni Tomazou
Grant from the Vienna Science and Technology Fund (WWTF), Life Sciences 2020, ID – LS20-045
Duration: 01/09/2021 to 31/08/2025
https://www.wwtf.at/funding/programmes/ls/LS20-045/pdf/ - How do leukemic cells escape natural killer cell-mediated surveillance?
CCRI responsible researcher: Michelle Buri (supervisor: Eva König)
Grant from the Austria Academy of Sciences (ÖAW), DOC fellowship, ID – 25905
Duration: 01/08/2021 to 31/08/2024
https://stipendien.oeaw.ac.at/stipendien/doc/doc-gefoerderte-personen - Establishing light-mediated clonal cancer models to investigate tumor initiation
CCRI responsible researcher: Adam Varady (supervisor: Martin Distel)
Grant from the Austria Academy of Sciences (ÖAW), DOC fellowship, ID – 25931
Duration: 01/08/2021 to 31/01/2024
https://stipendien.oeaw.ac.at/stipendien/doc/doc-gefoerderte-personen - Characterization of bacterial-fungal interactions: a basis for discovery of microbial biomarkers (BacFun)
CCRI responsible Principal Investigator: Thomas Lion
Grant from the Austrian Science Fund (FWF), Stand Alone Project, ID – P 34152
Duration: 01/08/2021 to 31/07/2024
https://www.fwf.ac.at/de/ - Molecular mechanisms of exocytosis coordination
CCRI responsible Principal Investigator: Kaan Boztug
Grant from the Austrian Science Fund (FWF), Stand Alone Project, ID – 34834
Duration: 01/07/2021 to 30/06/2024
https://www.fwf.ac.at/de/ - EWS-FLI1 fluctuations in Ewing Sarcoma
CCRI responsible Principal Investigator: Heinrich Kovar
Grant from the Austrian Science Fund (FWF), Stand Alone Project, ID – P 34341
Duration: 01/04/2021 to 31/03/2024
https://www.fwf.ac.at/de/news-presse/news/nachricht/nid/20211221-2710 - Cold atmospheric plasma for viral decontamination
CCRI responsible Principal Investigator: Thomas Lion
Grant from the Austrian Science Fund (FWF), CEUS Bilateral Joint Projects, ID – I 5293
Duration: 01/04/2021 to 31/03/2024
https://www.fwf.ac.at/en/ - Crossroads of immunometabolism and human deficiency
CCRI responsible researcher: Michael Kraakman (supervisor: Kaan Boztug)
Grant from the Austrian Science Fund (FWF), Lise Meitner Program, ID – M 3013
Duration: 01/01/2021 to 28/02/2023
https://www.fwf.ac.at/en/ - Automated minimal residual disease assessment in childhood acute myeloid leukemia (MYEFLOW)
CCRI responsible researcher: Margarita Maurer-Granofszky (Principal Investigator: Michael Dworzak)
Grant from the Vienna Business Agency, From Science to Products 2019, ID – 2841342
Duration: 15/03/2020 to 30/09/2024
https://viennabusinessagency.at/ - Identifying the Ewing Sarcoma cell-of-origin by cross-species enhancer activity analysis
CCRI responsible researcher: Sarah Grissenberger (supervisor: Martin Distel)
Grant from the Austria Academy of Sciences (ÖAW), DOC fellowship, ID – 25607
Duration: 01/03/2020 to 01/09/2022
https://stipendien.oeaw.ac.at/stipendien/doc/doc-gefoerderte-personen - CD Laboratory for “Next generation CAR-T cells”
Head of CD Laboratory and Coordinator: Manfred Lehner
Christian Doppler Association, Christian Doppler Lab
Duration: 01/11/2019 to 31/10/2026
https://christian-doppler.ccri.at/ - Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastomas (LIQUIDHOPE)
CCRI responsible Principal Investigator: Sabine Taschner-MandlCoordinator: Angelika Eggert, Charité, Germany
Grant from the Austrian Science Fund (FWF), TRANSCAN-2 JTC 2020, ID – I 4162
Duration: 01/04/2019 to 30/09/2022
https://transcan.eu/output-results/funded-projects/liquidhope.kl - Find tumor immune evasion strategies by cellular barcoding
CCRI responsible Principal Investigator: Eva König
Grant from the Austrian Science Fund (FWF), Stand Alone Project, ID – P 32001
Duration: 15/03/2019 to 14/09/2023
https://www.fwf.ac.at/en/ - Ultra-high-risk pediatric cancer – combinatorial drivers and therapeutic targets for precision medicine
CCRI responsible Principal Investigator and Coordinator: Sabine Taschner-Mandl
Additional CCRI Principal Investigators: Ruth Ladenstein
Grant from the Vienna Science and Technology Fund (WWTF), Life Sciences 2018, ID – LS18-111
Duration: 01/03/2019 to 28/02/2024
https://www.wwtf.at/funding/programmes/ls/LS18-111/ - Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy
CCRI responsible Principal Investigator and Coordinator: Eleni Tomazou
Grant from the Vienna Science and Technology Fund (WWTF), Life Sciences 2018, ID – LS18-049
Duration: 01/03/2019 to 28/02/2023
https://www.wwtf.at/funding/programmes/ls/LS18-049/
Internationally Funded Projects
- High resolution dissection of non-coding determinants of disease (B-ALLeles)
CCRI responsible researcher: Ana Patricia Kutschat (Supervisor: Davide Seruggia)
HE- Marie Sklodowska-Curie Action Postdoctoral Fellowship, Grant Agreement ID – 101061151
Duration: 01/11/2022 to 31/10/2024 - Towards an UNIque approach for artificial intelligence data-driven solutions to fight Childhood cAncer FOR Europe (UNICA4EU)
CCRI responsible Principal Investigator: Ruth Ladenstein
Coordinator: Samira Essiaf, SIOPE, Belgium
Pilot Projects and Preparatory Actions (PPPA), Grant Agreement ID – LC-01815952 / 101052609 UNICA4EU
Duration: 01/07/2022 to 30/06/2023 - European Reference Network on Paediatric Oncology – Year 6&7
CCRI responsible Principal Investigator and Coordinator: Ruth Ladenstein
EU4Health Work Programme, Grant Agreement ID – 101085543
Duration: 01/03/2022 to 31/08/2023 - Modeling Langerhans Cell Histiocytosis with patient derived iPSCs
CCRI responsible researcher: Giulio Abagnale (supervisor: Caroline Hutter)
Histiocytosis Association
Duration: 01/01/2022 to 31/12/2022
https://histio.org/grants/modeling-langerhans-cell-histiocytosis-with-patient-derived-ipscs/ - European Reference Network on Paediatric Cancer Connecting Facility-3
CCRI responsible Principal Investigator and Coordinator: Ruth Ladenstein
EU-CEF Grant Agreement ID – INEA/CEF/ICT/A2020/2393583
Duration: 01/09/2021 to 31/08/2023
https://paedcan.ern-net.eu/ - European rare disease research coordination and support action (ERICA)
CCRI responsible Principal Investigator: Ruth Ladenstein
Coordinator: Alberto Pereira, Leiden University Medical Center, the Nederlands,
H2020 Grant Agreement ID –964908
Duration: 01/03/2021 to 28/02/2025
https://erica-rd.eu/about/governance/executive-committee/ - Tracking Ewing sarcoma origin by developmental and trans-species genomics (ORIGIN)
CCRI responsible Principal Investigator and Coordinator: Heinrich KovarAdditional CCRI Principal Investigators: Martin Distel, Florian Halbritter
Alex´s Lemonade Stand Foundation (ALSF), Crazy 8 Initiative Award Program
Duration: 01/03/2021 to 28/02/2025
https://www.alexslemonade.org/ - Functional Interrogation of Non-coding DNA Sequences in leukemia development and drug resistance (FIND-seq)
CCRI responsible Principal Investigator and Awardee: Davide Seruggia
H2020 Grant Agreement ID – 947803
Duration: 01/03/2021 to 28/02/2026
https://erc.europa.eu/ - Implementing the digital survivorship passport to improve person-centered survivorship care (PanCareSurPass)
CCRI responsible Principal Investigator: Ruth Ladenstein
Coordinator: Desiree Grabow, Universitätsmedizin Mainz
H2020 Grant Agreement ID – 899999
Duration: 01/03/2021 to 28/02/2025
https://www.pancaresurpass.eu/ - Twinning research and education to improve survival in childhood solid tumors in Lithuania (TREL)
CCRI responsible principal investigator: Ruth Ladenstein
Coordinator: Jelena Rascon, Vilnius University Hospital Santaros Klinikos, Lithuania
H2020 Grant Agreement ID – 952438
Duration: 01/01/2021 to 31/12/2023
https://cordis.europa.eu/project/id/952438 - Validation of Actionable Genomic Aberrations in a Paediatric Oncology Network for Doctorate students (VAGABOND)
CCRI responsible Principal Investigator: Heinrich Kovar
Coordinator: Jan Molenaar, Prinses Máxima Centrum, the Netherlands
H2020 Grant Agreement ID – 956285
Duration: 01/12/2020 to 30/11/2024
https://vagabondnetwork.com/ - Integrated and standardized NGS workflows for Personalised therapy (INSTAND-NGS4P)
CCRI responsible Principal Investigators: Ruth Ladenstein, Kaan Boztug
Coordinator: Kurt Zatloukal, Medical University Graz
H2020 Grant Agreement ID – 874719
Duration: 01/01/2020 to 31/05/2025
https://www.instandngs4p.eu/ - Charting key molecules and mechanisms of human immune Dysregulation (iDysChart)
CCRI responsible Principal Investigator and Awardee: Kaan Boztug
H2020 – ERC Consolidator Grant, Grant Agreement ID – 820074
Duration 01/06/2019 to 31/05/2024
https://cordis.europa.eu/project/id/820074 - Childhood Leukemia: Overcoming distance between South America and Europe Regions (CLOSER)
CCRI responsible Principal Investigator: Sabine Strehl
Coordinator: Mireia Camos, Hospital Sant Joan de Déu de Barcelona, Spain
H2020 Grant Agreement ID – 825749
Duration: 01/01/2019 to 31/12/2023
https://closerleukemia.eu/ - European Joint Programme on Rare Diseases (EJP RD)
CCRI responsible Principal Investigator: Ruth Ladenstein
Coordinator: Daria Julkowska, Inserm, France
H2020 Grant Agreement ID – 825575
Duration: 01/01/2019 – 31/12/2023
https://www.ejprarediseases.org/ - PRedictive In-silico Multiscale Analytics (PRIMAGE)
CCRI responsible Principal Investigator: Ruth Ladenstein
Coordinator: Luis Martí-Bonmatí, La Fe, Spain
H2020 Grant Agreement ID – 826494
Duration: 01/12/2018 to 30/11/2022
https://www.primageproject.eu/wp-content/uploads/sites/6/2019/03/PRIMAGE-A1.pdf - ITCC Pediatric Preclinical POC Platform (ITCCP4)
CCRI responsible Principal Investigator: Heinrich Kovar
Coordinator: Stefan Pfister, Deutsches Krebsforschungszentrum DKFZ, Germany
EU-IMI Grant Agreement ID – 116064
Duration: 01/01/2017 to 31/12/2022
https://www.itccp4.eu/